Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway were also reported in SPTCL, which also suggested the potential mechanism of action of immunomodulatory drugs in SPTCL (15). This evidence concerns the gene MTOR and subcutaneous panniculitis-like T-cell lymphoma.